Back to search

Poland· PL-100195087

Testosteronum prolongatum Jelfa

A testosterone product containing testosteroni enantas, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 17 of our 19 countries.

ATC G03BA03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTestosteronum prolongatum JelfaATCG03BA03REGISTER NO.PL-100195087PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Testosterone is registered in 17 of 19 countries.

Countries holding a registration under ATC G03BA03 (testosterone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 10 of them publish a price we can compare per daily dose

Testosterone · ATC G03BA03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of testosterone costs, country by country.

Normalised to the WHO defined daily dose (0.12 g), the median price runs from <$0.001 in Czechia to $11.17 in Switzerland — a ×12412 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Testosterone · price per daily dose (0.12 g)

USD · FX 28 Sept 2026

  • CH Switzerland$11.17
  • CZ Czechia<$0.001
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Testosteroni enantas
Manufacturer
Bausch Health Ireland Ltd.
Country
Poland (PL)
ATC code
G03BA03
ATC class
Testosterone
Defined daily dose
0.12 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990230310

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

234 interactions on record for testosterone.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Testosterone · interactions on record

234 records

  • 10 severe
  • 108 moderate
  • 116 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • PazopanibL01EX03severe
  • PazopanibL01XE11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Testosterone in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All testosterone products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Testosteron Enantat Ever Valinject
  • Cyprus · Testosterone Enanthate Norma
  • Germany · Testogalen Depot, Testosteron Depot Zur Anwendung Bei Männern Und Bei Jungen Ab 6 Jahren Panpharma
  • France · Androtardyl, Testosterone Desma
  • United Kingdom (Northern Ireland) · Testosterone Enantate Alliance Pharmaceuticals
  • Greece · Testosterone Enanthate Norma
  • Italy · Testosterone Enantato Sit, Testoviron
  • Malta · Testosterone Enanthate Norma
  • Portugal · Testoviron Depot
  • Sweden · Testosteronenantat Galenpharma, Testosteronenantat Sit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/649e8ca3-c8f8-44f3-8a1b-df0394e302e5
GET /v1/drugs/649e8ca3-c8f8-44f3-8a1b-df0394e302e5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "100 mg/ml",
  "packaging": "05909990230310 ¦ Rp ¦ 47986\n5 amp. 1 ml",
  "substance": "Testosteroni enantas 100 mg",
  "common_name": "Testosteroni enantas",
  "pl_product_id": "100195087",
  "pozwolenie_nr": "02303",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about testosterone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.